The Chemours Company
CCSpecialty Chemicals
$13.19−1.27%As of Oct 29vs prior close
- Market cap
- $2B
- P/E (TTM)
- –
- P/E (FY1)
- 13.9×
- From 52W high
- −52.35%
- EPS (LTM)
- -$2.00
- Revenue (LTM)
- $5.8B
- Net margin
- -5.24%
- Dividend yield
- 2.67%
Nomior Score
40
Patient ValueSpeculativeBottom 29% of the scored universe
Growth39
Quality30
Value73
Momentum47
Resilience36
Growth
+0.81%revenue a year over 9 fiscal years
YE16 $5.4BLTM $5.8B
Connections
Revenue to profitQ2 YE26
The net loss was 17% of revenue, narrower by 6 pts on a year.
Who owns it
2funds